A new study led by researchers at Boston Children’s Hospital aims to determine whether monoclonal antibody Xolair (omalizumab) can stop or lessen the progression of asthma in high-risk children.
Over the last decade, pediatric medical devices have made up only about 25% of all healthcare devices approved by the FDA. The medical community is eager for change.
Immunization rates have decreased during the pandemic. Will we see a resurgence in infectious diseases as a result?
A bipartisan group of senators is pushing for a new commission to advise Congress on the best ways to modernize HIPAA. The 25-year-old law does not protect data recorded on personal electronic devices, like smartwatches or fitness trackers.
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
Recent experimental research shows a promising outlook for clinical trials in boys.
Clinicians spent over a year researching the unique risks of infants born to women with a confirmed SARS-CoV-2 infection. While some dangers have been identified, other study findings are promising.
During the pandemic, telehealth visits increased in popularity as more patients sought care from the privacy of their own homes. But lacking during these virtual physician visits are necessary blood work, tests and imaging services to make a...
Multisystem inflammatory syndrome in children (MIS-C) is a condition that causes widespread inflammation to a child’s vital organ systems, including the cardiovascular system.According to the CDC’s October 2020 statistics:
Number of confirmed MIS-C cases in 44 states...
An FDA-approved drug cocktail may provide improvement for many patients with this common hereditary disease.
- 1 of 7
- next ›